TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A study in male mice found that reduced testosterone combined with fructose led to more liver fat than either factor alone. The researchers linked the effect to changes in gut bacteria and higher intestinal pyruvate, but the findings have not established that the same process occurs in people.
In a study of male mice, reduced testosterone combined with a high-fructose diet produced more liver fat than either condition alone, researchers reported in the American Journal of Physiology-Endocrinology and Metabolism. The findings point to a possible role for gut bacteria and intestinal pyruvate, but they do not show that low testosterone makes sugar more damaging to the liver in people.
The research team, led by graduate student Hiroki Takahashi and Associate Professor Naoki Harada at a graduate school of agriculture, studied eight-week-old male mice. Some underwent castration to reduce testosterone, while others received a sham operation. The animals were assigned to six groups based on testosterone status, fructose exposure and whether they received antibiotics.
Low testosterone or fructose intake alone caused only modest changes in liver triglycerides, the researchers reported. Together, the conditions produced a significant increase in fat accumulation and worsened fatty liver. Mice with reduced testosterone that consumed fructose also had heavier livers; that increase was smaller in mice given antibiotics.
The team found changes in gut bacterial composition and liver gene activity, alongside higher pyruvate levels in the cecum, a section of the intestine. In experiments with primary liver cells taken from mice, pyruvate and fructose acted together to increase neutral lipid accumulation. These findings support a possible biological pathway, but the cell experiments and antibiotic results do not by themselves establish how the process works in humans.
What the Mouse Findings Suggest
The results offer a possible explanation for how hormone levels, diet and gut microbes may interact in fatty liver development. Rather than treating fructose intake or testosterone status as isolated factors, the study suggests their combined effects may matter in this animal model. That could help guide future research into mechanisms behind liver fat accumulation.
The condition under study, now called metabolic dysfunction-associated steatotic liver disease (MASLD), involves excess fat in the liver and is associated with factors including obesity, type 2 diabetes, low testosterone and high fructose consumption. The supplied report estimates that MASLD affects about 40% of adult men worldwide. The mouse findings do not establish that low testosterone changes an individual’s risk by a particular amount, nor do they show that changing testosterone or gut bacteria would prevent or treat the disease.
For readers, the practical limit is important: this is preclinical research, not evidence for a new dietary or medical intervention. It does not support self-diagnosis, testosterone treatment, or antibiotic use to address fatty liver. People concerned about liver health or hormone levels should seek advice from a qualified health professional.
Products Worth Considering
Blueair Blue Pure 511i Max Air Purifier for Home and Bedroom
Fitbit Versa 2 Health and Fitness Smartwatch with Bonus Bands
Philips Sonicare DiamondClean Smart 9300 Electric Toothbrush, Black
As an affiliate, we earn on qualifying purchases.
How Researchers Tested the Link
MASLD’s early stage can involve fat building up in liver tissue. Fructose is found in foods and drinks, including sugary beverages and some processed products. Earlier research has associated high fructose consumption and low testosterone with fatty liver, but the source report says it has been unclear how these factors interact and whether their combined effects exceed their separate effects.
To investigate, the researchers compared mice with reduced testosterone and control mice, with and without fructose exposure. Some fructose-fed groups also received antibiotics, allowing the team to examine whether disrupting gut bacteria altered the observed effects. They analyzed liver tissue and cells, blood plasma, intestinal organic acids and gut bacteria. Antibiotic treatment can affect more than one microbial process, so the group comparison is a clue to a possible role for the microbiome, not proof of a specific bacterial cause.
The team also tested mouse-derived liver cells outside the animals. Those experiments indicated that pyruvate and fructose can act together to increase lipid storage in the cells. The study therefore combines animal observations with a laboratory cell experiment; neither design directly measures disease risk or treatment effects in people.
“Changes in the gut microbiota led to increased levels of pyruvate within the intestine. Furthermore, experiments using mouse-derived primary hepatocytes revealed that pyruvate acts synergistically with fructose to promote neutral lipid accumulation in hepatocytes.”
— Hiroki Takahashi, graduate student and study lead
Human Effects Remain Unproven
The study used male mice and mouse-derived liver cells; the source report does not describe a human trial. It remains unknown whether reduced testosterone and dietary fructose interact in the same way in people, how large any effect might be, or whether the findings apply across different ages, diets or health conditions.
The results also do not establish which gut microbes or processes are responsible for the changes, whether pyruvate is the main driver in living animals, or whether the effect can be prevented without disrupting other functions of the gut microbiome. The study does not test a diet plan, testosterone therapy, antibiotics as treatment, or a drug for MASLD. Those questions require additional research.
Further Work on Pyruvate
Harada said the team plans to clarify how pyruvate promotes triglyceride accumulation, with the longer-term aim of informing research into possible medicines or dietary prevention approaches. The source report gives no timetable for follow-up studies or clinical testing.
Before the findings can guide care, researchers would need to test whether the interaction appears in human data and establish which biological steps matter. Until then, the reported mechanism should be treated as a research lead from animal and cell experiments, not a clinical recommendation.
Key Questions
Does this study show that low testosterone makes sugar more harmful to the human liver?
No. The researchers tested male mice and isolated mouse liver cells. The study does not establish the same effect in people.
What did the researchers find when testosterone was reduced and mice ate fructose?
The combination led to more liver fat than either reduced testosterone or fructose alone, according to the study. The researchers also observed changes in gut bacteria and higher intestinal pyruvate.
Does the study show that antibiotics can prevent fatty liver?
No. Antibiotics were used as part of the mouse experiment, and the increase in liver weight was smaller in one antibiotic-treated group. This does not establish antibiotics as a safe or effective treatment for fatty liver in people.
Should someone change testosterone treatment or diet because of these findings?
The study does not test treatment decisions or provide a clinical diet plan. Anyone concerned about testosterone levels, fructose intake or liver health should discuss their circumstances with a qualified health professional.
Source: sciencedaily.com
